The Risk of Hepatocellular Carcinoma After Directly Acting Antivirals for Hepatitis C Virus Treatment in Liver Transplanted Patients: Is It Real?

INTRODUCTION: Since directly acting antivirals (DAAs) for treatment of hepatitis C virus (HCV) were introduced, conflicting data emerged about the risk of hepatocellular carcinoma (HCC) after interferon (IFN)-free treatments. We present a case of recurrent, extra-hepatic HCC in a liver-transplanted...

Descripción completa

Detalles Bibliográficos
Autores principales: Strazzulla, Alessio, Maria Rita Iemmolo, Rosa, Carbone, Ennio, Concetta Postorino, Maria, Mazzitelli, Maria, De Santis, Mario, Di Benedetto, Fabrizio, Maria Cristiani, Costanza, Costa, Chiara, Pisani, Vincenzo, Torti, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203700/
https://www.ncbi.nlm.nih.gov/pubmed/28070200
http://dx.doi.org/10.5812/hepatmon.41933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203700/
https://www.ncbi.nlm.nih.gov/pubmed/28070200
http://dx.doi.org/10.5812/hepatmon.41933

Ejemplares similares